Latest Articles

Publication Date
Diagnosis of Endometriosis: Dual-Amplification Strategy Driven by Copper Nanoclusters.

Endometriosis is a prevalent gynecologic disorder associated with infertility and increased cancer risk, necessitating the development of sensitive and reliable diagnostic methods. Circulating microRNAs (miRNAs) have emerged as promising noninvasive …

Published: May 14, 2026, midnight
Empowering women's health with miRNA-integrated nanochemical approaches: from reproductive health to cancer care.

MicroRNAs (miRNAs), a category of small (18-25 nucleotides) non-coding transcripts that modulate gene expression at the post-transcriptional level, are necessary for regulatory processes in female reproduction, specifically in ovarian function …

Published: April 21, 2026, midnight
Comparative analysis of DNA methyltransferase 3 alpha and miR-29b expression in eutopic and ectopic endometrial tissues from endometriosis patients compared to healthy controls: A case-control study.

Epigenetic mechanisms, particularly the roles of DNA methylation and microRNAs, are increasingly recognized in the pathogenesis of endometriosis. DNA methyltransferase 3 (DNMT3) alpha, an important DNA methyltransferase, and miR-29b, a …

Published: April 15, 2026, midnight
MicroRNAs offer new hope in early diagnosis of PCOS, endometriosis - Daijiworld

MicroRNAs offer new hope in early diagnosis of PCOS, endometriosis Daijiworld

Published: April 6, 2026, 10:16 a.m.
Unlocking early detection, better treatment pathways for PCOS and endometriosis using microRNAs - The Hindu

Unlocking early detection, better treatment pathways for PCOS and endometriosis using microRNAs The Hindu

Published: April 6, 2026, 8:46 a.m.
Weekly review: New FDA compliance coming, microRNAs for endometriosis, and more - Contemporary OB/GYN

Weekly review: New FDA compliance coming, microRNAs for endometriosis, and more Contemporary OB/GYN

Published: March 28, 2026, 2:06 p.m.
Weekly review: New FDA compliance coming, microRNAs for endometriosis, and more - contemporaryobgyn.net

Weekly review: New FDA compliance coming, microRNAs for endometriosis, and more contemporaryobgyn.net

Published: March 28, 2026, 2:06 p.m.
Shared Pathophysiology and Early Detection Biomarkers in Endometriosis and Polycystic Ovary Syndrome (PCOS): Opportunities for AI-Enabled Screening.

Endometriosis and polycystic ovary syndrome (PCOS) are common, multifactorial gynecological disorders shaped by endocrine imbalance, immune dysfunction, metabolic disruption, genetic susceptibility, and environmental exposures. Despite their major contribution to infertility …

Published: March 28, 2026, midnight
Alla Vash-Margita, MD, FACOG, discusses microRNAs as earlier detection biomarkers for endometriosis - Contemporary OB/GYN

Alla Vash-Margita, MD, FACOG, discusses microRNAs as earlier detection biomarkers for endometriosis Contemporary OB/GYN

Published: March 24, 2026, 5:34 p.m.
MicroRNA Expression Profile in Endometriosis and Endometriosis-Associated Ovarian Cancer-Systematic Review.

Endometriosis-associated ovarian cancer comprises a special group of ovarian cancers that most probably originate from endometriosis foci. Several in vitro studies have shown that microRNA (miRNA) plays an important role …

Published: Feb. 20, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!